Dr. Al-Makki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
915 Mezzanine Dr
Suite A
Lafayette, IN 47905Phone+1 765-448-8000Fax+1 765-838-6350
Summary
- Dr. Akram Al-Makki is a nephrologist in Lafayette, IN and is affiliated with multiple hospitals in the area, including Indiana University Health Arnett Hospital, St. Elizabeth Hospital, and Indiana University Health White Memorial Hospital. He received his medical degree from Damascus University Faculty of Medicine and has been in practice 25 years. He is experienced in general nephrology, acute renal failure, chronic renal failure, and dialysis. He is also affiliated with Indiana University School of Medicine and Purdue University College of Pharmacy.
Clinical Expertise
- Dialysis, Acute renal failure, Chronic renal failure
Education & Training
- Detroit Medical Center/Wayne State UniversityFellowship, Nephrology, 1996 - 1998
- MedStar Health/Harbor HospitalResidency, Internal Medicine, 1993 - 1996
- Damascus University Faculty of MedicineClass of 1992
Certifications & Licensure
- IN State Medical License 1997 - 2025
- MI State Medical License 1995 - 1999
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- 2021-2022 Outstanding Outpatient Site Clerkship Preceptor Award from 3rd and 4th year medical students Indiana University School of Medicine - West Lafayette, 2022
- 2022 Adjunct/Volunteer Faculty Teaching Award Indiana University School of Medicine, 2022
- 2020 Trustee Teaching Award: The Indiana University Board of Trustees established this award to recognize outstanding teaching. Indiana University School of Medicine, 2020
- Join now to see all
Clinical Trials
- Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis Start of enrollment: 2007 Oct 01
- A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis Start of enrollment: 2006 Jul 01
- Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- 1 citationsErgocalciferol Versus Cholecalciferol in Non-Dialysis Dependent Chronic Kidney Disease Patients: A Small Retrospective Cohort Study.Akram Al-Makki, Kaitlin Frost, Sang-A Yun, Brian R. Overholser, Brian Shepler
Journal of Pharmacy & Pharmaceutical Sciences. 2019-12-02 - 119 citationsHypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary.Akram Al-Makki, Donald J. DiPette, Paul K. Whelton, M. Hassan Murad, Reem A. Mustafa
Hypertension. 2021-08-03 - 15 citationsEnd-Stage Kidney Disease in Areas of Armed Conflicts: Challenges and Solutions.Mohamed Sekkarie, Lina B. Murad, Akram Al-Makki, Fahd Al-Saghir, Oussama Rifai
Seminars in Nephrology. 2020-07-01
Journal Articles
- Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials. J. Pharm. Pha...Gruver J, Al-Makki A and Shepler B, J. Pharm. Pharm. Sci, 12/20/2023
- Impact of Race-Free eGFR on Racial Disparity in Receiving Timely Outpatient Nephrology Care: an Observational StudyGunderman D, Fricker G, Kondury K, Moe S, Al-Makki A, JGIM, 9/19/2023
- Single-Pill Combination versus Single-Agent Pills Treatment in Patients with Hypertension: An Overview of ReviewsAbdallah El Alayli, Romina Brignardello-Petersen, Sara Jdiaa, Veena Manja, Razan Mansour, Paul K. Whelton, Brian Rayner, Nizal Sarrafzadegan, Andrew E. Moran, Akram A..., Ann Clin Exp Hypertension, 4/24/2023
- Join now to see all
Abstracts/Posters
- Impact of race-free estimated Glomerular Filtration Rate (eGFR) on racial disparity in receiving timely outpatient nephrology care.Gabrielle E. Fricker, David J. Gunderman, Kasyap Kondury, Sharon M. Moe, Akram Al-Makki, American Society of Nephrology (ASN) Kidney Week 2023, Philadelphia, PA, 11/2023
- WHO Guideline for the pharmacological treatment of hypertension in adultsAkram Al-Makki, Donald DiPette, Paul K. Whelton, M. Hassan Murad, Reem A. Mustafa, Taskeen Khan, National Kidney Foundation’s Spring Clinical Meeting in 2022, Boston, MA, 4/7/2022
- Tenapanor: A New Treatment Option for Hyperphosphatemia in End Stage Kidney Disease.Tiffany Lin, PharmD Candidate, Akram Al-Makki, MD, Brian Shepler, PharmD, This poster won "Best PharmD Poster" award in October 2021 when presented at the Purdue Research Day., Purdue University, West Lafayette, IN, 10/2021
- Join now to see all
Lectures
- Resistant HypertensionLafayette, IN, 2014; Scottsdale, AZ, 2015 - 1/15/2015
- CKD-MBDIndiana University Health Arnett Hospital, Lafayette, IN - 1/23/2011
- ABIM Nephrology moduleIndianapolis, IN - 10/30/2010
- Join now to see all
Other
- Guideline for the pharmacological treatment of hypertension in adultWorld Health Organization's GDG, World Health Organization
https://apps.who.int/iris/bitstream/handle/10665/344424/9789240033986-eng.pdf
8/2021 - The Clinician's Illustrated Dictionary in Hypertension (thesis in Arabic)M. Jundi, A. Almakki, et al, Thesis
Damascus, Syria - 1/1/1992
Press Mentions
- 2022 Fall All-School Meeting recapOctober 10th, 2022
- Indiana University School of Medicine – Lafayette expanding program, enrollmentOctober 25th, 2012
- Trustee Teaching Award from Indiana University School of Medicine (IUSM)June 24th, 2020
- Join now to see all
Committees
- IUH representative, IUSM Faculty Steering Committee (FSC) 2020 - Present
- member, Education and Reserach Committee at Indiana University 2018 - 2020
Research History
- Principal InvestigatorA retrospective design study to compare the effect of calculation of eGFR without a race factor on referral to nephrology clinics. A collaborative study between Indiana University Health-Arnett and Indiana University School of Medicine-West Lafayette. Approved Protocol #: 15780 by IUSM IRB in 2022.2022 - 2023
- Principal InvestigatorPrincipal Investigator and an author in study titled “Ergocalciferol versus cholecalciferol in non-dialysis dependent chronic kidney disease patients: a retrospective cohort study” done at IU Health Arnett in collaboration with Purdue University College of Pharmacy. Presented at NKF meeting in 20182017 - 2018
- PhD research committee member and advisor for PhD student at Rocky Mountain University of Health Professions2003 - 2008
- Principal Investigator in: Affymax (AFX01-11) Trial (PEARL Study).
- Principal Investigator in: AZEPTIC Trial
- Member of Clinical Research Oversight Committee at Indiana University Health Arnett.
- Principal Investigator of the CentrosFLO Trial
Professional Memberships
- Fellow
- Fellow
External Links
- IUHAhttps://iuhealth.org/find-providers/provider/akram-al-makki-md-7847
- ORCID Connecting Research and Researchershttps://orcid.org/0000-0002-4510-8010/print
- IUSM Faculty https://medicine.iu.edu/faculty/5849/al-makki-akram
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: